Children's Hospital of Richmond at Virginia Commonwealth University
Richmond, Virginia, 23298, United States
NCT Number: NCT03998475
The purpose of this research study is to find out more about how to support young adults (ages 18-22) with type 1 diabetes as they prepare to transition from pediatric and adult endocrinology medical care.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Richmond, Virginia, 23298, United States
The overarching goal of the proposed trial is to improve diabetes self-management and glycemic control in young adults and prepare them for the transition to adult endocrinology. The current application will investigate the impact of a multisystem transition preparation intervention for young adults (ages 18-22) with T1D. Twenty-five young adults and a parent will be enrolled in a 6-month transition preparation program which will use a hybrid in-person and technology delivery structure. Providers will receive training highlighting their role preparing young adults for transition and provides practical tips to use in their communication with young adults. If effective, this multisystem intervention, designed to enhance T1D self-management and increase young adults' readiness for transition to adult healthcare during this critical developmental period, has the potential to inform clinical practice guidelines.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Both members of the youth/parent dyad must meet all eligibility criteria
Young adults
Parents
Medical providers
Exclusion criteria
Young adults
Parents
Young adult participants and parents will complete transition preparation sessions that include meeting with a health behavior coach for in-person sessions and review of materials sent electronically between study visits.
Time frame: 6 months
Number of study visits (attendance)
Time frame: 6 months
Number of opened electronic materials (e.g., opened messages in the patient health portal))
Time frame: 9 months
Young adult report on satisfaction with the program via an exit survey
Time frame: 9 months
Parent report on satisfaction with the program via an exit survey
Time frame: 9 months
Provider report on satisfaction with the program via an exit survey
Time frame: Baseline to 9 months
Measurement of hemoglobin A1c (A1c; reported as a percentage)
Time frame: 9 months
Participant report and medical record review of count of reported diabetes-related hospitalizations and complications
Time frame: Baseline to 9 months
Average of young adult and parent participant reports on the Diabetes Management Questionnaire (DMQ)
Time frame: Baseline to 9 months
Average of young adult and parent participant reports on the Transition Readiness Assessment Questionnaire (TRAQ)
Time frame: Baseline to 9 months
Participant (young adult) report on the Self-Efficacy for Diabetes Self-Management (SEDSM)
Time frame: Baseline to 9 months
Participant (young adult) report on the Pediatric Quality of Life Diabetes Module
Time frame: Baseline to 9 months
Average of young adult and parent participant reports on the Diabetes Family Responsibility Questionnaire (DFRQ)
Time frame: Baseline to 9 months
Average of young adult and parent participant reports on the Diabetes Family Conflict Scale (DFCS)
Time frame: Baseline to 9 months
Participant (young adult) report on the Center for Epidemiologic Studies Depression Scale (CESD)
Time frame: Baseline to 9 months
Participant (young adult) report on the Diabetes Distress Scale
Time frame: Baseline to 9 months
Participant (parent) report on the Diabetes Distress Scale for Parents of Teens with T1D
Time frame: Baseline to 9 months
Participant (young adult) report on the autonomy support sub-scale of the Barriers to Diabetes Adherence Questionnaire
Time frame: Baseline to 9 months
Participant (young adult) report on the Diabetes Adherence Problem Solving Questionnaire
Virginia Commonwealth University
Other
Implementing a Transition Preparation Intervention for Young Adults With Type 1 Diabetes in an Integrated Healthcare Setting
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05488119
Autoimmune Diseases, Diabetes Mellitus
Stanford, California, United States
View Trial DetailsNCT07696780
Autoimmune Diseases, Diabetes Mellitus
Bern, Canton of Bern, Switzerland
View Trial DetailsNCT05610111
Autoimmune Diseases, Diabetes Mellitus
Charlottesville, Virginia, United States
View Trial DetailsNCT06308549
Autoimmune Diseases, Diabetes Distress
Bad Mergentheim, Baden-Wurttemberg, Germany
View Trial Details